Protecting Patient Access to Cancer and Complex Therapies Act

Bill 118 hr 5391, also known as the Protecting Patient Access to Cancer and Complex Therapies Act, aims to address issues related to patient access to critical cancer treatments and other complex therapies. The bill seeks to ensure that patients have timely access to these life-saving treatments by streamlining the prior authorization process and reducing administrative burdens on healthcare providers.

Specifically, the bill requires insurance companies to implement electronic prior authorization systems for cancer and complex therapies, which will help expedite the approval process and reduce delays in treatment. Additionally, the bill establishes a standardized prior authorization form to simplify the process for healthcare providers and ensure consistency across different insurance plans.

Furthermore, the bill includes provisions to improve transparency and accountability in the prior authorization process, requiring insurance companies to report data on the number of prior authorization requests, approvals, and denials. This information will help identify trends and potential barriers to patient access to critical treatments. Overall, the Protecting Patient Access to Cancer and Complex Therapies Act aims to improve patient outcomes by ensuring timely access to necessary treatments, while also reducing administrative burdens on healthcare providers. The bill has received bipartisan support in Congress and is seen as a positive step towards addressing challenges in the healthcare system related to patient access to critical therapies.